Khammas, Ikhlas, et al. “Serum Levels of Advanced Oxidation Protein Products and Some Liver Function Markers in Chronic Myeloid Leukemia-Chronic Phase Patients Receiving Imatinib or Nilotinib”. Iraqi Journal of Pharmaceutical Sciences , vol. 34, no. 2, June 2025, pp. 40-46, https://doi.org/10.31351/vol34iss2pp40-46.